hsa-miR-4298
Submitted by Anonymous on Wed, 10/30/2019 - 22:16
Pubmed
| Gene symble | Title | PMID | Curated descirption | Category | Literature category |
|---|---|---|---|---|---|
| hsa-miR-4298 | Identification of microRNAs Specifically Expressed in Hepatitis C Virus-Associated Hepatocellular Carcinoma | 23390000 | Four (miR-4298, miR-575, miR-33b-3p and mir-610_x) and two (mir-517a_x, miR-21-3p) miRNAs were found to be exclusively expressed by liver donors and normal livers, respectively | mechanism | BC/OC research |
| hsa-miR-4298 | MiR-23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells | 23553990 | We identified eight miRNAs (miR-1274a, miR-196b, miR-4298, miR-181c, miR-181d, miR-23a, miR-27a and miR-24-2) that were located in the amplified regions and were upregulated in GC | mechanism | BC/OC research |
| hsa-miR-4298 | Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma | 28931080 | No significant correlation was found between survival rates (PFS and OS) and the expression levels of miR-451a and miR-4298 in GBM patients | biomarker | BC/OC research |
| hsa-miR-4298 | Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma | 28931080 | Based on the profiling result of serum miRNAs in GBM patients, we first carried out qRT-PCR on 3 miRNAs (miR-451a, miR-485-3p and miR-4298) in an new cohort (24 GBM patients and 12 healthy volunteers) to validate the microarray data | mechanism | BC/OC research |
Survival analysis